347 related articles for article (PubMed ID: 8492319)
21. Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma.
Griffin TW; Richardson C; Houston LL; LePage D; Bogden A; Raso V
Cancer Res; 1987 Aug; 47(16):4266-70. PubMed ID: 3496960
[TBL] [Abstract][Full Text] [Related]
22. Combined antitumor therapy with the chemotherapeutic drug doxorubicin and an anti-transferrin receptor immunotoxin: in vitro and in vivo studies.
Griffin TW; Stocl M; Collins J; Fernandes J; Maher VE
J Immunother (1991); 1992 Jan; 11(1):12-8. PubMed ID: 1734944
[TBL] [Abstract][Full Text] [Related]
23. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
Gridley DS; Slater JM; Stickney DR
J Biol Response Mod; 1989 Dec; 8(6):593-602. PubMed ID: 2513378
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents.
Muraszko K; Sung C; Walbridge S; Greenfield L; Dedrick RL; Oldfield EH; Youle RJ
Cancer Res; 1993 Aug; 53(16):3752-7. PubMed ID: 8339287
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates.
Byers VS; Pimm MV; Scannon PJ; Pawluczyk I; Baldwin RW
Cancer Res; 1987 Oct; 47(19):5042-6. PubMed ID: 3497715
[TBL] [Abstract][Full Text] [Related]
26. Anti-tumor activity of a blocked ricin immunotoxin with specificity against the cluster-5A antigen associated with human small-cell lung cancer.
Zangemeister-Wittke U; Collinson AR; Fisch I; Jones RM; Waibel R; Lehman HP; Stahel RA
Int J Cancer; 1993 Jul; 54(6):1028-35. PubMed ID: 8392978
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of antitumor immunotoxins by liposomal monensin.
Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V
J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of proliferating lens epithelium with antitransferrin receptor immunotoxin.
Goins KM; Ortiz JR; Fulcher SF; Handa JT; Jaffe GJ; Foulks GN; Cobo LM
J Cataract Refract Surg; 1994 Sep; 20(5):513-6. PubMed ID: 7996406
[TBL] [Abstract][Full Text] [Related]
29. Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice.
Pearson JW; FitzGerald DJ; Willingham MC; Wiltrout RH; Pastan I; Longo DL
Cancer Res; 1989 Jul; 49(13):3562-7. PubMed ID: 2499420
[TBL] [Abstract][Full Text] [Related]
30. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
Shah SA; Halloran PM; Ferris CA; Levine BA; Bourret LA; Goldmacher VS; Blättler WA
Cancer Res; 1993 Mar; 53(6):1360-7. PubMed ID: 7680284
[TBL] [Abstract][Full Text] [Related]
31. Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice.
Pearson JW; Sivam G; Manger R; Wiltrout RH; Morgan AC; Longo DL
Cancer Res; 1989 Sep; 49(18):4990-5. PubMed ID: 2504482
[TBL] [Abstract][Full Text] [Related]
32. Cure of multidrug-resistant human B-cell lymphoma xenografts by combinations of anti-B4-blocked ricin and chemotherapeutic drugs.
Liu C; Lambert JM; Teicher BA; Blättler WA; O'Connor R
Blood; 1996 May; 87(9):3892-8. PubMed ID: 8611717
[TBL] [Abstract][Full Text] [Related]
33. Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin.
Roy DC; Ouellet S; Le Houillier C; Ariniello PD; Perreault C; Lambert JM
J Natl Cancer Inst; 1996 Aug; 88(16):1136-45. PubMed ID: 8757193
[TBL] [Abstract][Full Text] [Related]
34. In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain.
Fulton RJ; Uhr JW; Vitetta ES
Cancer Res; 1988 May; 48(9):2626-31. PubMed ID: 3258547
[TBL] [Abstract][Full Text] [Related]
35. Immunotoxins to the murine transferrin receptor: intracavitary therapy of mice bearing syngeneic peritoneal tumors.
Bjorn MJ; Groetsema G
Cancer Res; 1987 Dec; 47(24 Pt 1):6639-45. PubMed ID: 3499979
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of gamma-interferon in ascitic and solid tumor models of human ovarian cancer.
Malik ST; Knowles RG; East N; Lando D; Stamp G; Balkwill FR
Cancer Res; 1991 Dec; 51(24):6643-9. PubMed ID: 1742738
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts.
Molthoff CF; Pinedo HM; Schlüper HM; Rutgers DH; Boven E
Int J Cancer; 1992 Apr; 51(1):108-15. PubMed ID: 1563830
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer.
Calvete JA; Newell DR; Wright AF; Rose MS
Cancer Res; 1994 Sep; 54(17):4684-90. PubMed ID: 8062265
[TBL] [Abstract][Full Text] [Related]
39. Intratumour therapy of solid tumours with ricin-antibody conjugates.
Kanellos J; McKenzie IF; Pietersz GA
Immunol Cell Biol; 1989 Apr; 67 ( Pt 2)():89-99. PubMed ID: 2786496
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of growing pigment epithelial cells by a receptor-directed immunotoxin.
Davis AA; Whidby DE; Privette T; Houston LL; Hunt RC
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2514-9. PubMed ID: 2265991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]